Some states are turning to a main drug in the opioid crisis to execute prisoners

Empty jail cell.
(Image credit: iStockphoto)

A synthetic opioid called fentanyl, which can be 50 times stronger than heroin and 100 times more powerful than morphine, is behind tens of thousands of the U.S. deaths last year in the opioid overdose and addiction crisis. Two states, Nevada and Nebraska, have plans to use fentanyl as the key ingredient in a lethal-injection cocktail as soon as January.

Doctors and opponents of capital punishment argue that the states are essentially performing medical experiments on death row inmates. Death penalty supporters blame the critics for the dearth of tested lethal-injection drugs, as pharmaceutical companies have refused to sell those drugs to the 31 states that have capital punishment. Either way, "there's cruel irony that at the same time these state governments are trying to figure out how to stop so many from dying from opioids, that they now want to turn and use them to deliberately kill someone," Austin Sarat, a law professor at Amherst College, tells The Washington Post.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.